JP2022512781A5 - - Google Patents
Info
- Publication number
- JP2022512781A5 JP2022512781A5 JP2021521816A JP2021521816A JP2022512781A5 JP 2022512781 A5 JP2022512781 A5 JP 2022512781A5 JP 2021521816 A JP2021521816 A JP 2021521816A JP 2021521816 A JP2021521816 A JP 2021521816A JP 2022512781 A5 JP2022512781 A5 JP 2022512781A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024213792A JP2025038016A (ja) | 2018-10-30 | 2024-12-06 | 同種異系の造血幹細胞移植の方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862752828P | 2018-10-30 | 2018-10-30 | |
| US62/752,828 | 2018-10-30 | ||
| US201862773873P | 2018-11-30 | 2018-11-30 | |
| US62/773,873 | 2018-11-30 | ||
| US201962882362P | 2019-08-02 | 2019-08-02 | |
| US62/882,362 | 2019-08-02 | ||
| PCT/US2019/058973 WO2020092655A1 (en) | 2018-10-30 | 2019-10-30 | Methods for allogeneic hematopoietic stem cell transplantation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024213792A Division JP2025038016A (ja) | 2018-10-30 | 2024-12-06 | 同種異系の造血幹細胞移植の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022512781A JP2022512781A (ja) | 2022-02-07 |
| JP2022512781A5 true JP2022512781A5 (https=) | 2022-11-07 |
| JPWO2020092655A5 JPWO2020092655A5 (https=) | 2022-11-07 |
Family
ID=70462151
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521816A Pending JP2022512781A (ja) | 2018-10-30 | 2019-10-30 | 同種造血幹細胞移植の方法 |
| JP2024213792A Pending JP2025038016A (ja) | 2018-10-30 | 2024-12-06 | 同種異系の造血幹細胞移植の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024213792A Pending JP2025038016A (ja) | 2018-10-30 | 2024-12-06 | 同種異系の造血幹細胞移植の方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210379195A1 (https=) |
| EP (1) | EP3877415A4 (https=) |
| JP (2) | JP2022512781A (https=) |
| KR (1) | KR20210086683A (https=) |
| CN (1) | CN113301923A (https=) |
| AU (1) | AU2019374055A1 (https=) |
| BR (1) | BR112021008437A2 (https=) |
| CA (1) | CA3117366A1 (https=) |
| IL (1) | IL282637A (https=) |
| MX (1) | MX2021004579A (https=) |
| SG (1) | SG11202104084WA (https=) |
| WO (1) | WO2020092655A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110740641A (zh) | 2016-11-30 | 2020-01-31 | 杰克逊实验室 | 具有改善的人先天免疫细胞发育的人源化小鼠模型 |
| CA3079215A1 (en) | 2017-10-24 | 2019-05-02 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of cd117+ cells |
| CN121555430A (zh) | 2018-05-11 | 2026-02-24 | 比姆医疗股份有限公司 | 使用可编程碱基编辑器系统取代病原性氨基酸的方法 |
| EP3959242A4 (en) * | 2019-04-24 | 2023-09-13 | Magenta Therapeutics, Inc. | ANTRACYCLINE ANTIBODY-DRUG CONJUGATES AND THEIR USES |
| EP3958899A4 (en) * | 2019-04-24 | 2023-08-02 | Magenta Therapeutics, Inc. | ANTI-CD117 ANTIBODY-DRUG CONJUGATES AND THEIR USES |
| EP3958909A4 (en) * | 2019-04-24 | 2024-01-10 | Magenta Therapeutics, Inc. | ANTI-CD117 ANTIBODY DRUG CONJUGATES AND USES THEREOF |
| GB202015226D0 (en) * | 2020-09-25 | 2020-11-11 | Adc Therapeutics S A | Pyrrol obenzodiazepine-antibody conugates and uses thereof |
| US12496303B2 (en) * | 2020-10-19 | 2025-12-16 | Washington University | Conditioning agents for use in allogeneic hematopoietic stem cell transplantation |
| US20250041339A1 (en) | 2021-11-19 | 2025-02-06 | The Trustees Of The University Of Pennsylvania | Engineered Pan-Leukocyte Antigen CD45 to Facilityate CAR T Cell Therapy |
| AU2022421979A1 (en) * | 2021-12-22 | 2024-08-01 | The Jackson Laboratory | Humanized mouse models |
| WO2023118608A1 (en) * | 2021-12-23 | 2023-06-29 | Universität Basel | Discernible cell surface protein variants of cd45 for use in cell therapy |
| EP4486784A1 (en) * | 2022-03-01 | 2025-01-08 | CSL Innovation Pty Ltd | Methods of bone marrow conditioning |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6558662B2 (en) * | 1997-11-14 | 2003-05-06 | The General Hospital Corporation | Treatment of hematologic disorders |
| NZ607906A (en) * | 2010-08-18 | 2015-11-27 | Theresa Deisher | Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| HK1249534A1 (zh) * | 2015-04-06 | 2018-11-02 | 哈佛大学校长及研究员协会 | 用於非清髓性预处理的组合物和方法 |
| CN109641051A (zh) * | 2016-06-17 | 2019-04-16 | 美真达治疗公司 | 用于耗尽细胞的组合物和方法 |
| BR112018076306A2 (pt) * | 2016-06-17 | 2019-03-26 | Magenta Therapeutics, Inc. | composições e métodos para a supressão de células cd117+ |
| CA3117367A1 (en) * | 2018-10-30 | 2020-05-07 | Magenta Therapeutics, Inc. | Anti-cd45 antibodies and conjugates thereof |
| WO2020219959A1 (en) * | 2019-04-24 | 2020-10-29 | Magenta Therapeutics, Inc. | Anti-cd45 antibody drug conjugates and uses thereof |
| JP2022535527A (ja) * | 2019-06-04 | 2022-08-09 | マジェンタ セラピューティクス インコーポレイテッド | 自己免疫疾患を治療するための方法および組成物 |
| EP4051711A4 (en) * | 2019-11-01 | 2024-02-21 | Magenta Therapeutics, Inc. | ANTI-CD45 ANTIBODIES AND THEIR CONJUGATES |
-
2019
- 2019-10-30 JP JP2021521816A patent/JP2022512781A/ja active Pending
- 2019-10-30 KR KR1020217016249A patent/KR20210086683A/ko active Pending
- 2019-10-30 WO PCT/US2019/058973 patent/WO2020092655A1/en not_active Ceased
- 2019-10-30 SG SG11202104084WA patent/SG11202104084WA/en unknown
- 2019-10-30 AU AU2019374055A patent/AU2019374055A1/en active Pending
- 2019-10-30 EP EP19877673.4A patent/EP3877415A4/en active Pending
- 2019-10-30 BR BR112021008437-1A patent/BR112021008437A2/pt not_active IP Right Cessation
- 2019-10-30 MX MX2021004579A patent/MX2021004579A/es unknown
- 2019-10-30 CA CA3117366A patent/CA3117366A1/en active Pending
- 2019-10-30 CN CN201980085584.8A patent/CN113301923A/zh active Pending
-
2021
- 2021-04-26 IL IL282637A patent/IL282637A/en unknown
- 2021-04-29 US US17/244,864 patent/US20210379195A1/en active Pending
-
2024
- 2024-12-06 JP JP2024213792A patent/JP2025038016A/ja active Pending